Leej twg ua Zerbaxa?

2024 Tus sau: Michael Samuels | [email protected]. Kawg hloov kho: 2023-12-16 01:44

KENILWORTH, NJ.-- (BUSINESS WIRE)-Merck (NYSE: MRK), paub tias yog MSD sab nraum Tebchaws Meskas thiab Canada, hnub no tshaj tawm tias US Food and Drug Administration (FDA) tau pom zoo lawm. Merck cov Ntxiv Daim Ntawv Thov Tshuaj Tshiab (sNDA) rau kev siv ZERBAXA^® (ceftolozane thiab tazobactam) rau kev kho mob ntawm cov neeg mob 18

Ib yam li ntawd, tib neeg nug, Zerbaxa nqi pes tsawg?

Cov tus nqi rau Zerbaxa cov hmoov txhaj tshuaj rau txhaj (1 g-0.5 g) nyob ib puag ncig $ 1, 317 rau kev muab 10 hmoov rau kev txhaj tshuaj, nyob ntawm lub tsev muag tshuaj koj mus ntsib. Nqe yog rau cov neeg siv nyiaj ntsuab nkaus xwb thiab tsis siv tau nrog cov phiaj xwm kev pov hwm.

Ib yam nkaus, puas yog Zerbaxa npog Pseudomonas? Ceftolozane-tazobactam (cov Zerbaxa ; Merck & Co. Inc., Whitehouse Station, NJ) tau pom zoo siv los ntawm US Food and Drug Administration (FDA) hauv 2014 thiab los ntawm European Medicines Agency hauv 2015. Qhov kev sib xyaw no tau pom tias muaj kev ua haujlwm zoo hauv vitro tiv thaiv MDR. P. aeruginosa (5).

Ib qho ntxiv, puas yog Zerbaxa npog enterococcus?

Zerbaxa muaj cov haujlwm dav dav tiv thaiv kab mob gram-tsis zoo, suav nrog Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, thiab Pseudomonas aeruginosa, ntxiv rau tiv thaiv gram zoo suav nrog Bacteroides fragilis, Streptococcus anginosus, Streptococcus constell

Zerbaxa siv rau dab tsi?

Zerbaxa (ceftolozane / tazobactam) yog ib qho tshuaj tua kab mob ua ke thiab beta-lactamase inhibitor siv los kho cov kab mob sib kis hauv plab (cIAI), thiab cov kab mob nyuab nyuab (cUTI), suav nrog pyelonephritis, tshwm sim los ntawm cov kab mob me me.